{"slideshow_credits": null, "snippet": "The British pharmaceutical giant GlaxoSmithKline pushed back the deadline for its $2.59 billion hostile bid for Human Genome Sciences til June 29.", "abstract": "The British pharmaceutical giant GlaxoSmithKline pushed back the deadline for its $2.59 billion hostile bid for Human Genome Sciences til June 29.", "section_name": "Business Day", "print_page": null, "document_type": "blogpost", "byline": {"person": [{"firstname": "Mark", "role": "reported", "lastname": "SCOTT", "rank": 1, "organization": ""}], "original": "By MARK SCOTT"}, "web_url": "http://dealbook.nytimes.com/2012/06/08/glaxo-extends-deadline-for-human-genome-sciences-takeover-offer/", "lead_paragraph": null, "headline": {"main": "Glaxo Extends Deadline for Human Genome Sciences Bid", "kicker": "DealBook"}, "_id": "4fdf29c832439115e30b700a", "word_count": "230", "multimedia": [], "pub_date": "2012-06-08T09:15:32Z", "source": "The New York Times", "news_desk": null, "keywords": [{"name": "organizations", "value": "GlaxoSmithKline PLC", "rank": "1"}, {"name": "organizations", "value": "Human Genome Sciences Inc", "rank": "2"}, {"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "rank": "1"}], "blog": [], "subsection_name": "Dealbook", "type_of_material": "Blog"}